Emcure Pharmaceuticals: Domestic Recovery, Global Growth and the GLP-1 Opportunity
Moneylife Digital Team 04 September 2026
Emcure Pharmaceuticals Limited (Emcure) is transitioning from a predominantly acute and tender-led generics profile to a more balanced platform of chronic, specialty and complex therapies. The...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Moneylife Stockgraders
Moneylife Digital Team 04 September 2026
Guidelines                                        1. The Grader captures the three factors that determine investments: valuation, returns and price strength. Our grader captures these three parameters.   2. In this system, A is a...
IPO Review: Rays of Belief Ltd
Moneylife Digital Team 03 September 2026
Rays of Belief Limited (RBL), incorporated in 2017 and headquartered in New Delhi, is a for-profit social enterprise providing personalised intervention plans for children with neuro-developmental disorders, including autism spectrum...
Divi’s Laboratories: Growth Accelerates, but Valuation Leaves Little Room for Error
Moneylife Digital Team 03 September 2026
Divi’s Laboratories (Divi’s) is a leading Indian pharmaceuticals company specialising in generic APIs (active pharmaceutical ingredients) (bulk drugs used as key components in medicines) and intermediates and a global player in custom...
IPO Review: Deepa Jewellers Ltd
Moneylife Digital Team 02 September 2026
Deepa Jewellers Limited (DJL), incorporated in 2016 and headquartered in Hyderabad, is engaged in retail and wholesale trading of gold and diamond jewellery, offering traditional and contemporary designs. The company’s portfolio spans...
Free Helpline
Legal Credit
Feedback